Return to top of page

Webinar on Symptomatic Relief for Alzheimer’s/March 15

March 6, 2017   |   Alliance for Aging Research Team   |   ACT-AD (Accelerate Cure/Treatments for Alzheimer's Disease), Alzheimer's Disease
Webinar on Symptomatic Relief for Alzheimer’s/March 15

On Wednesday, March 15, at 12 p.m. EST, the Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD) Coalition will hold a one-hour webinar on symptomatic relief for Alzheimer’s disease. The webinar will feature experts who discuss the burden of Alzheimer’s disease on patients and their families, advances in neurobiology, and provide an update on clinical development activities to improve the treatment of Alzheimer’s disease symptoms.

Featured experts will include:

Jeffrey L. Cummings, M.D., Sc.D., Director, Lou Ruvo Center for Brain Health, Camille and Larry Ruvo Chair for Brain Health, Cleveland Clinic

Richard Malamut, M.D., Chief Medical Officer, Senior Vice President, Research & Development, Avanir Pharmaceuticals

Joan Amatniek, M.D., Msc, Senior Director, CNS, Global Clinical Development, Otsuka Pharmaceutical

Cynthia A. Bens, Executive Director, Accelerate Cure/Treatments for Alzheimer’s Disease (ACT-AD)

Candid Seal of Platinum Transparency 2022

The Alliance for Aging Research is a proud recipient of Candid’s Platinum Seal of Transparency.

Charity Navigator logo

The Alliance for Aging Research is proud to be rated a 4-star charity by Charity Navigator.

Living Longer and Loving It

Sign up for our monthly e-mail newsletter for the latest information on
scientific research on aging and health.